SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GLGC Gene Logic
An SI Board Since July 1998
Posts SubjectMarks Bans Symbol
360 30 0 GLGC
Emcee:  Steven Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
360Nah, that was my final speculation. I got what I needed to get from Wall Street Mike McFarland12/26/2009
359sorry to hear that! best of luck with other choices!mlkr-2/25/2009
358<i>One of myriad ways to destroy capital--do nothing.</i> One of thSteve Lokness12/25/2009
35728 million when I posted that, a good warning, now down to 2 million, not much Mike McFarland-2/25/2009
356you made the right thing! dont quit!mlkr-2/24/2009
355just for fun I set up a new thread with the new name I see that the yahoo quoteMike McFarland-1/14/2008
354Friday December 14, 2007 Gene Logic Inc. Completes Sale of Genomics Assets to OMike McFarland-12/18/2007
353Ore Pharmaceuticals--New symbol will be ORXE <i>shareholders have approveMike McFarland-12/11/2007
352NOTICE OF SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 10, 2007 TO THMike McFarland-11/10/2007
351The quarterly report is online, looks like they'll be taking a loss of $3.5MMike McFarland-11/9/2007
350Might as well have called it ACK! Pharma premier.net what a dog, I mean cat. &lMike McFarland-11/5/2007
349>>Gene Logic Selects New Company Name: Ore Pharmaceuticals Inc. Tuesday Octuck-10/30/2007
348Genomics Assets to Ocimum Biosolutions for $10 Million Good to have that done.Mike McFarland-10/15/2007
347Five year chart of CLDA shows it up 600%, while GLGC has declined about 85% in tMike McFarland-10/4/2007
346I hope AFFX gave them volume discounts. That has to be tens of millions of dollaMike McFarland-9/14/2007
345<i>The Company has processed more than 200,000 microarrays to obtain genomSteve Lokness-9/14/2007
344Gene Logic Collaborates with FDA to Explore Genomic Data Quality Metrics RelatedMike McFarland-9/14/2007
343Not entirely off topic... I saw a lecture by a Stanford research scientist regaMike McFarland-9/9/2007
342This year at the DR summit: Thomas Barnes, Ph.D., Senior Vice President of DiscMike McFarland-9/2/2007
341American biotech burns through $300m, changes course, signs many deals, has entMike McFarland-8/27/2007
340Yup, so far today good for .01 cent up move. steveSteve Lokness-8/27/2007
339Gene Logic and Solvay Pharmaceuticals Enter Agreement to Discover New DevelopmenMike McFarland-8/27/2007
338Ha, isn't that the truth! Of course it was up on half a million shares yestMike McFarland-8/24/2007
337Cashboy; GLGC has become the Rodney Dangerfied of the stock market. steveSteve Lokness-8/24/2007
336'repositioning and development agreement with Merck Serono, a division of MeMike McFarland-8/23/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News